Deregulation of the PI3K/AKT/PTEN pathway occurs through multiple mechanisms including loss of the tumour suppressor PTEN along with activating mutations in PIK3CA (the catalytic subunit of PI3Kα), AKT1 and PIK3R1 (the regulatory subunit of the PI3K complex) [1–3]. Here, PIK3CA is linked to neoplasm.